These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28245859)

  • 41. Early-stage esophageal squamous cell carcinoma treated with californium-252 neutron brachytherapy: clinical report on 16 cases.
    Liu H; Wang Q; Jia X; Liu B; Wang CK
    Tumori; 2013; 99(2):172-5. PubMed ID: 23748810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early changes in flow cytometric DNA profiles induced by californium-252 neutron brachytherapy in squamocellular carcinomas of the uterine cervix.
    Tacev T; Zaloudík J; Janáková L; Vagunda V
    Neoplasma; 1998; 45(2):96-101. PubMed ID: 9687890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
    Lee HJ; Kim YS; Shin SS; Nam JH; Kim YT; Han S; Choi EK
    Tumori; 2012; 98(5):615-21. PubMed ID: 23235757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix.
    Maruyama Y; VanNagell JR; Yoneda J; Donaldson E; Gallion H; Rowley K; Kryscio R; Beach JL
    Cancer; 1987 Apr; 59(8):1500-5. PubMed ID: 3028603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
    Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
    Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?
    Yuce Sari S; Guler OC; Gultekin M; Onal HC; Yildiz F
    Oncol Res Treat; 2017; 40(9):523-527. PubMed ID: 28848218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.
    Kim YJ; Kim JY; Kim Y; Lim YK; Jeong J; Jeong C; Kim M; Lim MC; Seo SS; Park SY
    Strahlenther Onkol; 2016 Dec; 192(12):922-930. PubMed ID: 27734106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
    J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
    Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
    Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
    Refaat T; Donnelly ED; Gentile M; Novak C; Yuan Y; Khedr GA; Helenowksi I; Lurain J; Schink J; Rademaker A; Sathiaseelan V; Strauss JB; Small W
    Am J Clin Oncol; 2016 Apr; 39(2):196-203. PubMed ID: 24487420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
    Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.